BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34239048)

  • 1. Systemic enhancement of serotonin signaling reverses social deficits in multiple mouse models for ASD.
    Walsh JJ; Llorach P; Cardozo Pinto DF; Wenderski W; Christoffel DJ; Salgado JS; Heifets BD; Crabtree GR; Malenka RC
    Neuropsychopharmacology; 2021 Oct; 46(11):2000-2010. PubMed ID: 34239048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT release in nucleus accumbens rescues social deficits in mouse autism model.
    Walsh JJ; Christoffel DJ; Heifets BD; Ben-Dor GA; Selimbeyoglu A; Hung LW; Deisseroth K; Malenka RC
    Nature; 2018 Aug; 560(7720):589-594. PubMed ID: 30089910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice.
    Lawson SK; Gray AC; Woehrle NS
    Behav Brain Res; 2016 Nov; 314():52-64. PubMed ID: 27439030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D
    Guo Q; Ebihara K; Fujiwara H; Toume K; Awale S; Araki R; Yabe T; Dong E; Matsumoto K
    J Ethnopharmacol; 2019 May; 236():231-239. PubMed ID: 30862522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram attenuates social behavior deficits in the BTBR T
    Cai Y; Wang L; Nalvarte I; Xiao R; Li X; Fan X
    Brain Res Bull; 2019 Aug; 150():75-85. PubMed ID: 31047973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism.
    Moy SS; Teng BL; Nikolova VD; Riddick NV; Simpson CD; Van Deusen A; Janzen WP; Sassano MF; Pedersen CA; Jarstfer MB
    Neuropharmacology; 2019 Jan; 144():301-311. PubMed ID: 30399367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of nucleus accumbens synaptic transmission signals a critical period for the rescue of social deficits in a mouse model of autism spectrum disorder.
    Matthiesen M; Khlaifia A; Steininger CFD; Dadabhoy M; Mumtaz U; Arruda-Carvalho M
    Mol Brain; 2023 May; 16(1):46. PubMed ID: 37226266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of the MDMA Model to Address Social Impairment in Autism.
    Chaliha D; Mamo JC; Albrecht M; Lam V; Takechi R; Vaccarezza M
    Curr Neuropharmacol; 2021; 19(7):1101-1154. PubMed ID: 33388021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens.
    Rein B; Raymond K; Boustani C; Tuy S; Zhang J; St Laurent R; Pomrenze MB; Boroon P; Heifets B; Smith M; Malenka RC
    Sci Adv; 2024 Apr; 10(17):eadl6554. PubMed ID: 38657057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
    Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder.
    Fonteneau M; Brugoux A; Jaccaz D; Donello JE; Banerjee P; Le Merrer J; Becker JA
    Neuropharmacology; 2024 May; 248():109889. PubMed ID: 38401792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.
    Folkes OM; Báldi R; Kondev V; Marcus DJ; Hartley ND; Turner BD; Ayers JK; Baechle JJ; Misra MP; Altemus M; Grueter CA; Grueter BA; Patel S
    J Clin Invest; 2020 Apr; 130(4):1728-1742. PubMed ID: 31874107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.
    Rhine MA; Parrott JM; Schultz MN; Kazdoba TM; Crawley JN
    Autism Res; 2019 Mar; 12(3):401-421. PubMed ID: 30653853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
    Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
    J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABAB receptor agonist STX209 reverses the autism‑like behaviour in an animal model of autism induced by prenatal exposure to valproic acid.
    Jiang S; Xiao L; Sun Y; He M; Gao C; Zhu C; Chang H; Ding J; Li W; Wang Y; Sun T; Wang F
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 5-HT
    Esaki H; Sasaki Y; Nishitani N; Kamada H; Mukai S; Ohshima Y; Nakada S; Ni X; Deyama S; Kaneda K
    Eur J Pharmacol; 2023 May; 946():175653. PubMed ID: 36907260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.
    Ryu YK; Park HY; Go J; Choi DH; Choi YK; Rhee M; Lee CH; Kim KS
    Psychopharmacology (Berl); 2021 Jul; 238(7):1833-1845. PubMed ID: 33723660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of social deficits by subchronic oxytocin in two autism mouse models.
    Teng BL; Nikolova VD; Riddick NV; Agster KL; Crowley JJ; Baker LK; Koller BH; Pedersen CA; Jarstfer MB; Moy SS
    Neuropharmacology; 2016 Jun; 105():61-71. PubMed ID: 26748053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished social interaction incentive contributes to social deficits in mouse models of autism spectrum disorder.
    Rein B; Yan Z; Wang ZJ
    Genes Brain Behav; 2020 Jan; 19(1):e12610. PubMed ID: 31602784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT
    O'Reilly KC; Connor M; Pierson J; Shuffrey LC; Blakely RD; Ahmari SE; Veenstra-VanderWeele J
    Psychopharmacology (Berl); 2021 Apr; 238(4):1111-1120. PubMed ID: 33511450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.